Novel synthetic agonists of TLR9

Details for Australian Patent Application No. 2008282172 (hide)

Owner Idera Pharmaceuticals, Inc.

Inventors Yu, Dong; Wang, Daqing; Agrawal, Sudhir; Kandimalla, Ekambar R.; Lakshmi, Bhagat; Reddy Putta, Mallikarjuna

Agent Freehills

Pub. Number AU-A-2008282172

PCT Pub. Number WO2009/018431

Priority 61/015,292 20.12.07 US; 60/953,251 01.08.07 US; 60/983,601 30.10.07 US; 60/987,151 12.11.07 US

Filing date 31 July 2008

Wipo publication date 5 February 2009

International Classifications

C07H 21/04 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

A61K 31/711 (2006.01) - Natural deoxyribonucleic acids, i.e. containing only 2'-deoxyriboses attached to adenine, guanine, cytosine or thymine and having 3'-5' phosphodiester links

A61K 39/00 (2006.01) Medicinal preparations containing antigens or antibodies

A61K 39/35 (2006.01) Medicinal preparations containing antigens or antibodies - Allergens

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

Event Publications

4 February 2010 PCT application entered the National Phase

  PCT publication WO2009/018431 Priority application(s): WO2009/018431

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008282174-Lighting apparatus

2008282166-Process for the production of high purity elemental silicon